Gene · 970
Papers4,349
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,421 to 1,440 of 4,349
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immunotherapy for Management of Thymic Epithelial Tumors: A Double-Edged Sword. | Cancers (Basel) | 2022 | 35565190 | PubTator, text mining | PubMed |
| The Effect of Hyperthermia and Radiotherapy Sequence on Cancer Cell Death and the Immune Phenotype of Breast Cancer Cells. | Cancers (Basel) | 2022 | 35565180 | PubTator, text mining | PubMed |
| Enrichment of Tumor-Infiltrating B Cells in Group 4 Medulloblastoma in Children. | Int J Mol Sci | 2022 | 35563678 | PubTator, text mining | PubMed |
| Role of Programmed Cell Death Protein-1 and Lymphocyte Specific Protein Tyrosine Kinase in the Aryl Hydrocarbon Receptor- Mediated Impairment of the IgM Response in Human CD5+ Innate-Like B Cells. | Front Immunol | 2022 | 35558082 | PubTator, text mining | PubMed |
| Epithelial-to-mesenchymal transition promotes immune escape by inducing CD70 in non-small cell lung cancer. | Eur J Cancer | 2022 | 35550950 | PubTator, text mining | PubMed |
| The optimized core peptide derived from CABIN1 efficiently inhibits calcineurin-mediated T-cell activation. | Exp Mol Med | 2022 | 35550603 | PubTator, text mining | PubMed |
| Development and Validation of a Novel Hypoxia Score for Predicting Prognosis and Immune Microenvironment in Rectal Cancer. | Front Surg | 2022 | 35548187 | PubTator, text mining | PubMed |
| Current status and advances of immunotherapy in nasopharyngeal carcinoma. | Ther Adv Med Oncol | 2022 | 35547095 | PubTator, text mining | PubMed |
| The Immune System in Hypertension: a Lost Shaker of Salt 2021 Lewis K. Dahl Memorial Lecture. | Hypertension | 2022 | 35545942 | PubTator, text mining | PubMed |
| New insights into checkpoint inhibitor immunotherapy and its combined therapies in hepatocellular carcinoma: from mechanisms to clinical trials. | Int J Biol Sci | 2022 | 35541908 | PubTator, text mining | PubMed |
| The Extensive Regulation of MicroRNA in Immune Thrombocytopenia. | Clin Appl Thromb Hemost | 2022 | 35536600 | PubTator, text mining | PubMed |
| An integrative in-silico analysis discloses a novel molecular subset of colorectal cancer possibly eligible for immune checkpoint immunotherapy. | Biol Direct | 2022 | 35534873 | PubTator, text mining | PubMed |
| Immune Checkpoint Inhibitors in Acute Myeloid Leukemia: A Meta-Analysis. | Front Oncol | 2022 | 35530329 | PubTator, text mining | PubMed |
| Dysregulation of immune checkpoint proteins in hepatocellular carcinoma: Impact on metabolic reprogramming. | Curr Opin Pharmacol | 2022 | 35526340 | PubTator, text mining | PubMed |
| Dissecting the Role of Immune Checkpoint Regulation Patterns in Tumor Microenvironment and Prognosis of Gastric Cancer. | Front Genet | 2022 | 35518357 | PubTator, text mining | PubMed |
| A systematic comparison of FOSL1, FOSL2 and BATF-mediated transcriptional regulation during early human Th17 differentiation. | Nucleic Acids Res | 2022 | 35511484 | PubTator, text mining | PubMed |
| Somatic FOXC1 insertion mutation remodels the immune microenvironment and promotes the progression of childhood acute lymphoblastic leukemia. | Cell Death Dis | 2022 | 35504885 | PubTator, text mining | PubMed |
| The Spectrum of B Cell Functions in Atherosclerotic Cardiovascular Disease. | Front Cardiovasc Med | 2022 | 35497984 | PubTator, text mining | PubMed |
| Perspectives for Combining Viral Oncolysis With Additional Immunotherapies for the Treatment of Melanoma. | Front Mol Biosci | 2022 | 35495634 | PubTator, text mining | PubMed |
| Harnessing the chemokine system to home CAR-T cells into solid tumors. | Cell Rep Med | 2022 | 35492880 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/970/papers?page=72